Cyclic vomiting syndrome

Last updated
Cyclic vomiting syndrome
Other namesCyclical vomiting syndrome
Specialty Gastroenterology

Cyclic vomiting syndrome (CVS) is a chronic functional condition of unknown pathogenesis. CVS is characterized as recurring episodes lasting a single day to multiple weeks. Each episode is divided into four phases: inter-episodic, prodrome, vomiting, and recovery. Inter-episodic phase (symptom free phase), is characterized as no discernible symptoms, normal everyday activities can occur, and this phase typically lasts one week to one month. The prodrome phase is known as the pre-emetic phase, characterized by the initial feeling of an approaching episode, still able to keep down oral medication. Emetic or vomiting phase is characterized as intense persistent nausea, and repeated vomiting typically lasting hours to days. Recovery phase is typically the phase where vomiting ceases, nausea diminishes or is absent, and appetite returns. "Cyclic vomiting syndrome (CVS) is a rare abnormality of the neuroendocrine system that affects 2% of children." [1] This disorder is thought to be closely related to migraines and family history of migraines. [2] [3]

Contents

Signs and symptoms

AdultsChildren
Mean age of diagnosis 29–34 years old3–7 years old
Mean duration of episodes3–6 daysfew hours to 4 days
Mean Inter-episodic duration1–3 months1 week to 1 month
Presence of Prodrome phasecommoncommon
Recovery timelasting several dayslasting hours to days
Vomitinguniversal up to 6 times an houruniversal up to 6 times an hour
Abdominal paincommon (57–70%)common (68–80%)
Upper Gastrointestinal Complicationscommon (38%)common (22–32%)
Headachescommoncommon
Fever not commonnot common
Dehydration needing IV fluidscommoncommon with longer attacks
Family history with migrainescommon (30–70%)common (40–89%)
Psychiatric disorders commoncommon
Inter-episodic nausea/paincommonrare
Mitochondrial DNA disordersnot reportedreported
Cannabis usereportednot reported
Unpleasant triggerscommon (67%)common harder to pinpoint

Affected individuals may vomit or retch 6–12 times in an hour and an episode may last from a few hours to over three weeks and in some cases months, with a median episode duration of 41 hours. [4] Stomach acid, bile and, if the vomiting is severe, blood may be vomited. Some with the condition will ingest water to reduce the irritation of bile and acid on the esophagus during emesis. Between episodes, the affected individual is usually normal and healthy otherwise but can be in a weak state of fatigue or experience muscle pain. In approximately half of cases the attacks, or episodes, occur in a time-related manner. Each attack is stereotypical; that is, in any given individual, the timing, frequency and severity of attacks is similar. Some affected people experience episodes that progressively get worse when left untreated, occurring more frequently with reduced symptom free phase. [5]

Episodes may happen every few days, every few weeks or every few months, for some happening at common uniform times, typically mornings. [5] For other affected people, there is not a pattern in time that can be recognized. Some with the condition have a warning of an episodic attack; they may experience a prodrome, some documented prodromal symptoms include: unusually intense nausea and pallor, excess salivation, sweating, flushing, rapid/irregular heartbeat, diarrhea, anxiety/panic, food aversion, restlessness/insomnia, irritability, depersonalization, fatigue/listlessness, intense feelings of being hot or chilled, intense thirst, shivering/shaking, retching, tachypnea, abdominal pain/cramping, limb paresthesias, hyperesthesia, photophobia, phonophobia, headache, and dyspnea, heightened sensitivity, especially to light, though sensitivity to smell, sound, pressure, and temperature, as well as oncoming muscle pain and fatigue, are also reported by some patients. Many experiences a full panic attack when nausea begins and continue to panic once the vomiting has begun. Medications like Lorazepam, Alprazolam, and other benzodiazepines are prescribed by their doctors and instructed to take immediately at the onset of any of their CVS symptoms and/or triggers. Some prodromal symptoms are present inter-episodically as well as during acute phases of illness. The majority of affected people can identify triggers that may precede an attack. The most common are various foods, infections (such as colds), menstruation, extreme physical exertion, lack of sleep, and psychological stresses, both positive and negative.[ citation needed ]

An affected person may also be light-sensitive (photophobic), sound-sensitive (phonophobic) or, less frequently, temperature- or pressure-sensitive during an attack. [6] Some people also have a strong urge to bathe in warm or cold water. In fact, many people with CVS experience a compulsion to be submerged in hot water, and end up taking several baths during the duration of an episode. For some the psychological compulsion to be in hot water is so extreme that they cannot stop themselves from taking very long baths in near scalding hot water several times per day. For some of these people, they may have just finished taking a lengthy bath in extremely hot water and immediately feel this compulsion again and end up taking another bath right after drying off. Some people with the condition experience insomnia, diarrhea (GI complications), hot and cold flashes, and excessive sweating before an episode. Some report that they experience a restless sensation or stinging pain along the spine, hands, and feet followed by weakness in both legs. Some of these symptoms may be due to dehydration or hypokalemia from excessive vomiting, rather than the underlying cause of CVS.

Genetics

There is no known genetic pathogenesis for CVS. Recent studies suggest many affected individuals have a family history of related conditions, such as migraines, psychiatric disorders and gastrointestinal disorders. Inheritance is thought to be maternal, a possible genetic mitochondrial inheritance. Adolescents show higher possible mitochondrial inheritance and maternal inheritance than found in adults. Single base-pair and DNA rearrangements in the mitochondrial DNA (mtDNA) have been associated with these traits. [7] [8]

Diagnosis

The cause of CVS has not been determined and there are no diagnostic tests for CVS. Several other medical conditions, such as cannabinoid hyperemesis syndrome (CHS), can mimic the same symptoms, and it is important to rule these out. If all other possible causes have been excluded, a diagnosis of CVS using Rome criteria by a physician may be appropriate. [5]

Once formal investigations to rule out gastrointestinal or other causes have been conducted, these tests do not need to be repeated in the event of future episodes. [6]

Diagnostic criteria

Due to the lack of specific biomarkers available for the disorder, and if all other possible causes can be ruled out (such as intestinal malrotation), physicians rely on the Rome IV process criteria in order to diagnose patients. [5] Patients must meet all three of the following criteria to receive diagnosis:

  1. Stereotypical episodes of acute vomiting each with a duration of less than 1 week
  2. A history of at least three discrete episodes in the prior year and at least two episodes in the past 6 months, each occurring at least 1 week apart
  3. An absence of vomiting between episodes, but other milder symptoms can be present between cycles

Criteria must be fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis. A history of family history of migraine headaches can also be used in facilitating diagnosis. [9]

Treatment

Treatment for cyclic vomiting syndrome depends on the evident phase of the disorder. [10]

Because the symptoms of CVS are similar (or perhaps identical) to those of the disease well-identified as "abdominal migraine," prophylactic migraine medications, such as topiramate and amitriptyline, have seen recent success in treatment for the prodrome and vomiting phases, reducing the duration, severity, and frequency of episodes. [11]

Therapeutic treatment for the prodromal phase, characterized by the anticipation of an episode, consists of sumatriptan (nasal or oral) an anti-migraine medication, anti-inflammatory drugs to reduce abdominal pain, and possible anti-emetic drugs. These options may be helpful in preventing an episode or reducing the severity of an attack. [12] [13]

The most common therapeutic strategies for those already in the vomiting phase are maintenance of salt balance by appropriate intravenous fluids. Sedation via high dose intravenous benzodiazepines, typically lorazepam, has been shown to shorten the length of emergency department stays for some patients. [14] Having vomited for a long period prior to attending a hospital, patients are typically severely dehydrated. For a number of patients, potent anti-emetic drugs such as ondansetron (Zofran) or granisetron (Kytril), and dronabinol (Marinol) may be helpful in either preventing an attack, aborting an attack, or reducing the severity of an attack. [15] Many patients seek comfort during episodes by taking prolonged showers and baths typically quite hot. The use of a heating pad may also help reduce abdominal pain. [2]

Lifestyle changes may be recommended, such as extended rest, reduction of stress, frequent small meals, and to abstain from fasting. A diet change may be recommended avoid food allergens, eliminating trigger foods such as chocolates, cheese, beer, and red wine. [16] [3]

Some patients experience relief from inhaled isopropyl alcohol. [17]

Intravenous Haloperidol may be an effective treatment. [18]

Prognosis

Fitzpatrick et al. (2007) identified 41 children with CVS. The mean age of the sample was 6 years at the onset of the syndrome, 8 years at first diagnosis, and 13 years at follow-up. As many as 39% of the children had resolution of symptoms immediately or within weeks of the diagnosis. Vomiting had resolved at the time of follow-up in 61% of the sample. Many children, including those in the remitted group, continued to have somatic symptoms such as headaches (in 42%) and abdominal pain (in 37%). [19]

Most children who have this disorder miss on average 24 school days a year. [16] The frequency of episodes is higher for some people during times of excitement. [16] Charitable organizations to support affected people and their families and to promote knowledge of CVS exist in several countries.

A 2005 study by Fleisher et al. identified 41 adults who had been previously seen for complaints compatible with CVS. The average age at presentation of the sample was 34 years, and the mean age at onset was 21 years. The mean duration of the CVS at the time of consultation was 12 years. Of the 39 patients surveyed, 85% had episodes that were fairly uniform in length. Most patients reported these attacks in the morning hours. Of those 39 patients, 32% were completely disabled and required financial support due to CVS. Despite this, data suggests that the prognosis for CVS is generally favorable. [2]

Complications can include dehydration, dental caries, or an esophageal tear. [20]

Epidemiology

The average age at onset is 3–7 years, with described cases as young as 6 days and as old as 73 years. [21] Typical delay in diagnosis from onset of symptoms is 3 years. [21] Females show a slight predominance over males. [21]

One study found that 3 in 100,000 five-year-olds are diagnosed with the condition. [22] Two studies on childhood CVS suggest nearly 2% of school-age children may have CVS. [23] [24]

History

Cyclic vomiting syndrome was first described in France by Swiss physician Henri Clermond Lombard [25] and first described in the English language by pediatrician Samuel Gee in 1882. [26]

It has been suggested that Charles Darwin's adult illnesses may have been due to this syndrome. [27] [ further explanation needed ]

See also

Related Research Articles

<span class="mw-page-title-main">Migraine</span> Disorder resulting in recurrent moderate-severe headaches

Migraine is a genetically influenced complex neurological disorder characterized by episodes of moderate-to-severe headache, most often unilateral and generally associated with nausea and light and sound sensitivity. Other characterizing symptoms may include nausea, vomiting, cognitive dysfunction, allodynia, and dizziness. Exacerbation of headache symptoms during physical activity is another distinguishing feature. Up to one-third of migraine sufferers experience aura: a premonitory period of sensory disturbance widely accepted to be caused by cortical spreading depression at the onset of a migraine attack. Although primarily considered to be a headache disorder, migraine is highly heterogenous in its clinical presentation and is better thought of as a spectrum disease rather than a distinct clinical entity. Disease burden can range from episodic discrete attacks, consisting of as little as several lifetime attacks, to chronic disease.

<span class="mw-page-title-main">Headache</span> Pain in the head, neck, or face

Headache, also known as cephalalgia, is the symptom of pain in the face, head, or neck. It can occur as a migraine, tension-type headache, or cluster headache. There is an increased risk of depression in those with severe headaches.

<span class="mw-page-title-main">Alice in Wonderland syndrome</span> Neurological disorder that distorts perception of objects size and distance

Alice in Wonderland syndrome (AIWS), also known as Todd's syndrome or dysmetropsia, is a neurological disorder that distorts perception. People with this syndrome may experience distortions in their visual perception of objects, such as appearing smaller (micropsia) or larger (macropsia), or appearing to be closer (pelopsia) or farther (teleopsia) than they are. Distortion may also occur for senses other than vision.

Functional gastrointestinal disorders (FGID), also known as disorders of gut–brain interaction, include a number of separate idiopathic disorders which affect different parts of the gastrointestinal tract and involve visceral hypersensitivity and motility disturbances.

Functional constipation, known as chronic idiopathic constipation (CIC), is constipation that does not have a physical (anatomical) or physiological cause. It may have a neurological, psychological or psychosomatic cause. A person with functional constipation may be healthy, yet has difficulty defecating.

<span class="mw-page-title-main">Small intestinal bacterial overgrowth</span> Medical condition

Small intestinal bacterial overgrowth (SIBO), also termed bacterial overgrowth, or small bowel bacterial overgrowth syndrome (SBBOS), is a disorder of excessive bacterial growth in the small intestine. Unlike the colon, which is rich with bacteria, the small bowel usually has fewer than 100,000 organisms per millilitre. Patients with bacterial overgrowth typically develop symptoms which may include nausea, bloating, vomiting, diarrhea, malnutrition, weight loss and malabsorption, which is caused by a number of mechanisms.

<span class="mw-page-title-main">Vertigo</span> Type of dizziness where a person has the sensation of moving or surrounding objects moving

Vertigo is a condition in which a person has the sensation of movement or of surrounding objects moving when they are not. Often it feels like a spinning or swaying movement. It may be associated with nausea, vomiting, perspiration, or difficulties walking. It is typically worse when the head is moved. Vertigo is the most common type of dizziness.

<span class="mw-page-title-main">Rumination syndrome</span> Medical condition

Rumination syndrome, or merycism, is a chronic motility disorder characterized by effortless regurgitation of most meals following consumption, due to the involuntary contraction of the muscles around the abdomen. There is no retching, nausea, heartburn, odour, or abdominal pain associated with the regurgitation as there is with typical vomiting, and the regurgitated food is undigested. The disorder has been historically documented as affecting only infants, young children, and people with cognitive disabilities . It is increasingly being diagnosed in a greater number of otherwise healthy adolescents and adults, though there is a lack of awareness of the condition by doctors, patients, and the general public.

<span class="mw-page-title-main">Eosinophilic esophagitis</span> Allergic inflammatory condition of the esophagus

Eosinophilic esophagitis (EoE) is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. In healthy individuals, the esophagus is typically devoid of eosinophils. In EoE, eosinophils migrate to the esophagus in large numbers. When a trigger food is eaten, the eosinophils contribute to tissue damage and inflammation. Symptoms include swallowing difficulty, food impaction, vomiting, and heartburn.

<span class="mw-page-title-main">Intestinal pseudo-obstruction</span> Medical condition

Intestinal pseudo-obstruction (IPO) is a clinical syndrome caused by severe impairment in the ability of the intestines to push food through. It is characterized by the signs and symptoms of intestinal obstruction without any lesion in the intestinal lumen. Clinical features mimic those seen with mechanical intestinal obstructions and can include abdominal pain, nausea, abdominal distension, vomiting, dysphagia and constipation depending upon the part of the gastrointestinal tract involved.

The Rome process and Rome criteria are an international effort to create scientific data to help in the diagnosis and treatment of functional gastrointestinal disorders, such as irritable bowel syndrome, functional dyspepsia and rumination syndrome. The Rome diagnostic criteria are set forth by Rome Foundation, a not for profit 501(c)(3) organization based in Raleigh, North Carolina, United States.

<span class="mw-page-title-main">Sucrose intolerance</span> Medical condition

Sucrose intolerance or genetic sucrase-isomaltase deficiency (GSID) is the condition in which sucrase-isomaltase, an enzyme needed for proper metabolism of sucrose (sugar) and starch, is not produced or the enzyme produced is either partially functional or non-functional in the small intestine. All GSID patients lack fully functional sucrase, while the isomaltase activity can vary from minimal functionality to almost normal activity. The presence of residual isomaltase activity may explain why some GSID patients are better able to tolerate starch in their diet than others with GSID.

<span class="mw-page-title-main">Mitochondrial neurogastrointestinal encephalopathy syndrome</span> Medical condition

Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE) is a rare autosomal recessive mitochondrial disease. It has been previously referred to as polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudoobstruction. The disease presents in childhood, but often goes unnoticed for decades. Unlike typical mitochondrial diseases caused by mitochondrial DNA (mtDNA) mutations, MNGIE is caused by mutations in the TYMP gene, which encodes the enzyme thymidine phosphorylase. Mutations in this gene result in impaired mitochondrial function, leading to intestinal symptoms as well as neuro-ophthalmologic abnormalities. A secondary form of MNGIE, called MNGIE without leukoencephalopathy, can be caused by mutations in the POLG gene.

In medicine, a prodrome is an early sign or symptom that often indicates the onset of a disease before more diagnostically specific signs and symptoms develop. It is derived from the Greek word prodromos, meaning "running before". Prodromes may be non-specific symptoms or, in a few instances, may clearly indicate a particular disease, such as the prodromal migraine aura.

The classification of all headaches, including migraines, is organized by the International Headache Society, and published in the International Classification of Headache Disorders (ICHD). The current version, the ICHD-3 beta, was published in 2013.

Cannabinoid hyperemesis syndrome (CHS) is recurrent nausea, vomiting, and cramping abdominal pain that can occur due to prolonged, high-dose cannabis use. These symptoms may be relieved temporarily by taking a hot shower or bath. Complications may include kidney failure and electrolyte problems.

Migralepsy is a rare condition in which a migraine is followed, within an hour period, by an epileptic seizure. Because of the similarities in signs, symptoms, and treatments of both conditions, such as the neurological basis, the psychological issues, and the autonomic distress that is created from them, they individually increase the likelihood of causing the other. However, also because of the sameness, they are often misdiagnosed for each other, as migralepsy rarely occurs.

Abdominal aura, also known as visceral aura and epigastric aura, is a type of somatosensory aura that typically manifests as abdominal discomfort in the form of nausea, malaise, hunger, or pain. Abdominal aura is typically associated with epilepsy, especially temporal lobe epilepsy, and it can also be used in the context of migraine. The term is used to distinguish it from other types of somatosensory aura, notably visual disturbances and paraesthesia. The abdominal aura can be classified as a somatic hallucination. Pathophysiologically, the abdominal aura is associated with aberrant neuronal discharges in sensory cortical areas representing the abdominal viscera.

Abdominal migraine(AM) is a functional disorder that usually manifests in childhood and adolescence, without a clear pathologic mechanism or biochemical irregularity. Children frequently experience sporadic episodes of excruciating central abdominal pain accompanied by migrainous symptoms like nausea, vomiting, severe headaches, and general pallor. Abdominal migraine can be diagnosed based off clinical criteria and the exclusion of other disorders.

<span class="mw-page-title-main">CD55 deficiency</span> Medical condition

CD55deficiency, also called DAF deficiency or CHAPLE syndrome, is a rare genetic disorder of the immune system. CHAPLE stands for "CD55 deficiency with hyper-activation of complement, angiopathic thrombosis, and severe protein-losing enteropathy (PLE)." The disorder usually manifests in childhood and can be life-threatening. This condition was described by Özen, et al. in 2017.

References

  1. ↑ Lee LY, Abbott L, Mahlangu B, Moodie SJ, Anderson S (September 2012). "The management of cyclic vomiting syndrome: a systematic review". European Journal of Gastroenterology & Hepatology. 24 (9): 1001–6. doi:10.1097/MEG.0b013e328355638f. PMID   22634989. S2CID   19343777.
  2. 1 2 3 Fleisher DR, Gornowicz B, Adams K, Burch R, Feldman EJ (December 2005). "Cyclic Vomiting Syndrome in 41 adults: the illness, the patients, and problems of management". BMC Medicine. 3 (1): 20. doi: 10.1186/1741-7015-3-20 . PMC   1326207 . PMID   16368014.
  3. 1 2 Abell TL, Adams KA, Boles RG, Bousvaros A, Chong SK, Fleisher DR, et al. (April 2008). "Cyclic vomiting syndrome in adults". Neurogastroenterology and Motility. 20 (4): 269–84. doi:10.1111/j.1365-2982.2008.01113.x. hdl: 2027.42/72300 . PMID   18371009. S2CID   8718836.
  4. ↑ Li BU, Fleisher DR (August 1999). "Cyclic vomiting syndrome: features to be explained by a pathophysiologic model". Digestive Diseases and Sciences. 44 (8 Suppl): 13S–18S. doi:10.1023/A:1026662402734. PMID   10490033. S2CID   295292.
  5. 1 2 3 4 Bhandari S, Jha P, Thakur A, Kar A, Gerdes H, Venkatesan T (April 2018). "Cyclic vomiting syndrome: epidemiology, diagnosis, and treatment". Clinical Autonomic Research. 28 (2): 203–209. doi:10.1007/s10286-018-0506-2. PMID   29442203. S2CID   3324893.
  6. 1 2 Lindley KJ, Andrews PL (September 2005). "Pathogenesis and treatment of cyclical vomiting". Journal of Pediatric Gastroenterology and Nutrition. 41 (Suppl 1): S38-40. doi: 10.1097/01.scs.0000180299.04731.cb . PMID   16131963. S2CID   25060114.
  7. ↑ "Cyclic vomiting syndrome?". medlineplus.gov. US: National Institutes of Health . Retrieved 1 September 2022.
  8. ↑ Venkatesan T, Zaki EA, Kumar N, et al. (October 2014). "Quantitative pedigree analysis and mitochondrial DNA sequence variants in adults with cyclic vomiting syndrome". BMC Gastroenterology . 14 (1): 181. doi: 10.1186/1471-230X-14-181 . PMC   4287476 . PMID   25332060.
  9. ↑ "Rome IV Criteria". Rome Foundation. 16 January 2016. Archived from the original on 23 July 2022. Retrieved 23 July 2022.
  10. ↑ "Cyclic Vomiting Syndrome: Symptoms, Diagnosis, Treatment & Causes". Cleveland Clinic. Retrieved 2021-03-17.
  11. ↑ Paul SP, Barnard P, Soondrum K, Candy DC (May 2012). "Antimigraine (low-amine) diet may be helpful in children with cyclic vomiting syndrome". Journal of Pediatric Gastroenterology and Nutrition. 54 (5): 698–9. doi: 10.1097/MPG.0b013e31824ca0a2 . PMID   22302150.
  12. ↑ Kowalczyk, Monika; Parkman, Henry; Ward, Lawrence (2010). "Adult Cyclic Vomiting Syndrome Successfully Treated with Intranasal Sumatriptan". Journal of General Internal Medicine. 25 (1): 88–91. doi:10.1007/s11606-009-1162-y. ISSN   0884-8734. PMC   2811593 . PMID   19911235.
  13. ↑ Vidula, Mahesh K.; Wadhwani, Anil; Roberts, Kaleigh; Berkowitz, Lyle L. (2014). "Use of a once-daily NSAID in treatment of cyclic vomiting syndrome". Journal of General Internal Medicine. 29 (3): 543–546. doi:10.1007/s11606-013-2624-9. ISSN   1525-1497. PMC   3930795 . PMID   24129856.
  14. ↑ Liu, Joy; Young, Kimberly; Silvernale, Casey; Sawhney, Veer; Ludwig, Andrew; Cangemi, David; Lembo, Anthony; Kuo, Braden (October 2018). "Acute Management of Cyclic Vomiting Syndrome Patients in the Emergency Department Setting: 440". Official journal of the American College of Gastroenterology | ACG. 113: S256. ISSN   0002-9270.
  15. ↑ "Understanding Cyclic Vomiting Syndrome Doctor Q&A". Migraine Again. 2021-01-26. Retrieved 2021-03-17.
  16. 1 2 3 Li BU, Lefevre F, Chelimsky GG, Boles RG, Nelson SP, Lewis DW, et al. (September 2008). "North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome". Journal of Pediatric Gastroenterology and Nutrition. 47 (3): 379–93. doi: 10.1097/MPG.0b013e318173ed39 . PMID   18728540. S2CID   3910188.
  17. ↑ "Inhaled Isopropyl Alcohol Superior to Oral Ondansetron as an Antiemetic". New England Journal of Medicine Journal Watch jwatch.org. 2018-03-09.
  18. ↑ Schwartz, Brad E.; Baker, Karen Keller; Bleinberger, Andrew J.; Lleshi, Amina; Cruz-Cano, Raul (2021). "Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis". World Journal of Emergency Medicine. 12 (3): 228–231. doi:10.5847/wjem.j.1920-8642.2021.03.012. ISSN   1920-8642. PMC   8188283 . PMID   34141040.
  19. ↑ Fitzpatrick E, Bourke B, Drumm B, Rowland M (April 2008). "The incidence of cyclic vomiting syndrome in children: population-based study". The American Journal of Gastroenterology. 103 (4): 991–5, quiz 996. doi:10.1111/j.1572-0241.2007.01668.x. PMID   18070235. S2CID   25698609.
  20. ↑ "Cyclical vomiting syndrome". NHS Gov.UK. 2017-10-18.
  21. 1 2 3 Li BU, Misiewicz L (September 2003). "Cyclic vomiting syndrome: a brain-gut disorder". Gastroenterology Clinics of North America. 32 (3): 997–1019. doi:10.1016/S0889-8553(03)00045-1. PMID   14562585.
  22. ↑ Drumm BR, Bourke B, Drummond J, McNicholas F, Quinn S, Broderick A, et al. (October 2012). "Cyclical vomiting syndrome in children: a prospective study". Neurogastroenterology and Motility. 24 (10): 922–7. doi:10.1111/j.1365-2982.2012.01960.x. PMID   22762244. S2CID   22054244.
  23. ↑ Abu-Arafeh I, Russell G (November 1995). "Cyclical vomiting syndrome in children: a population-based study". Journal of Pediatric Gastroenterology and Nutrition. 21 (4): 454–8. doi: 10.1097/00005176-199511000-00014 . PMID   8583299. S2CID   20399340.
  24. ↑ Cullen KJ, Ma Cdonald WB (August 1963). "The periodic syndrome: its nature and prevalence". The Medical Journal of Australia. 50 (2): 167–73. doi:10.5694/j.1326-5377.1963.tb24739.x. PMID   14024194.
  25. ↑ Lombard HC (1861). "Description d'une névrose de la digestion, caractérisée par des crises périodiques de vomissements et une profonde modification de l'assimilation". Gazette Médicale de Paris: 312.
  26. ↑ Gee S (1882). "On fitful or recurrent vomiting". St Bartholomew Hospital Reports. 18: 1.
  27. ↑ Hayman JA (December 2009). "Darwin's illness revisited". BMJ. 339: b4968. doi:10.1136/bmj.b4968. PMID   20008377. S2CID   32616636.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.